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Abstract
Background: The differentiation of corneal limbal stem cells (LSCs) from human pluripotent stem cells (hPSCs) has
great power as a novel treatment for ocular surface reconstruction and for modeling corneal epithelial renewal.
However, the lack of profound understanding of the true LSC population identity and the regulation of LSC
homeostasis is hindering the full therapeutic potential of hPSC-derived LSCs as well as primary LSCs.
Methods: The differentiation trajectory of two distinct hPSC lines towards LSCs was characterized extensively
using immunofluorescence labeling against pluripotency, putative LSC, and mature corneal epithelium markers.
Cell counting, flow cytometry, and qRT-PCR were used to quantify the differences between distinct populations
observed at day 11 and day 24 time points. Initial differentiation conditions were thereafter modified to support the
maintenance and expansion of the earlier population expressing ABCG2. Immunofluorescence, qRT-PCR, population
doubling analyses, and transplantation into an ex vivo porcine cornea model were used to analyze the phenotype
and functionality of the cell populations cultured in different conditions.
Results: The detailed characterization of the hPSC differentiation towards LSCs revealed only transient expression of a
cell population marked by the universal stemness marker and proposed LSC marker ABCG2. Within the ABCG2-positive
population, we further identified two distinct subpopulations of quiescent ΔNp63α-negative and proliferative ΔNp63α-
positive cells, the latter of which also expressed the acknowledged intestinal stem cell marker and suggested LSC marker
LGR5. These populations that appeared early during the differentiation process had stem cell phenotypes distinct from
the later arising ABCG2-negative, ΔNp63α-positive third cell population. Importantly, novel culture conditions modulating
the Wnt and BMP signaling pathways allowed efficient maintenance and expansion of the ABCG2-positive populations.
In comparison to ΔNp63α-positive hPSC-LSCs cultured in the initial culture conditions, ABCG2-positive hPSC-LSCs in the
novel maintenance condition contained quiescent stem cells marked by p27, demonstrated notably higher population
doubling capabilities and clonal growth in an in vitro colony-forming assay, and increased regenerative potential in the
ex vivo transplantation model.
(Continued on next page)
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: heli.skottman@tuni.fi
†Meri Vattulainen and Tanja Ilmarinen contributed equally to this work.
1Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön
katu 34, 33520 Tampere, Finland
Full list of author information is available at the end of the article
Vattulainen et al. Stem Cell Research & Therapy          (2019) 10:236 
https://doi.org/10.1186/s13287-019-1354-2
(Continued from previous page)
Conclusions: The distinct cell populations identified during the hPSC-LSC differentiation and ABCG2-positive LSC
maintenance may represent functionally different limbal stem/progenitor cells with implications for regenerative efficacy.
Keywords: Human pluripotent stem cells, Stem cell differentiation, Limbal stem cells, Stem cell hierarchy, Stem cell
maintenance, Wnt signaling, ABCG2, Limbal stem cell deficiency
Background
The constant homeostatic regeneration of the human
corneal epithelium (CE) is maintained by limbal stem
cells (LSCs) that reside in their specific niche structures
in the palisades of Vogt of the limbus [1]. Disturbances
in the renewal process due to LSC dysfunction or loss
manifest as a clinical condition called limbal stem cell
deficiency (LSCD) that may in unilateral cases be treated
with autologous cultured limbal epithelial transplant-
ation (CLET) [2]. On the other hand, differentiation of
LSCs from human pluripotent stem cells (hPSCs), in-
cluding both human embryonic stem cells (hESCs) and
induced pluripotent stem cells (hiPSCs), represents a
promising therapy option for patients suffering from the
bilateral condition [3, 4].
One of the most critical current challenges in the field
of LSC therapies, with both primary and hPSC-derived
cells, is the identification and maintenance of the clinically
relevant LSC population. No specific single marker has
been discovered to fill this gap. Thus, the phenotypic iden-
tification of LSCs currently relies on the expression of
several stemness-related markers, combined with the ab-
sence of cytokeratins (CKs) 3 and 12 that mark terminally
differentiated CE [5]. The tumor protein p63 is currently
acknowledged as the classical identifier of colony-forming
LSCs with proven clinical relevance and thus serves as a
hallmark of high-quality CLET transplants [6, 7]. More-
over, among different p63 isoforms, ΔNp63α has been
found to be the most abundantly expressed by LSCs [8, 9].
Other suggested LSC markers include ABCB5, BMI1,
Frizzled-7, C/EBPδ, and CK15 [10–13]. In addition, stu-
dies in mice have pointed to ABCG2 being a universal
marker of stemness in several tissues [14] and describing a
slow-cycling subpopulation of colony-forming primary
LSCs in humans [15, 16]. Thus, ABCG2 has been widely
acknowledged as a marker for putative LSCs in vivo [5].
Especially in the development of hPSC-based thera-
pies, the potential presence of undifferentiated (UD)
cells with tumorigenic potential among the transplant-
able cells raises an obvious safety concern. Markers that
allow purification of the clinically relevant cell material
by sorting would significantly promote both the safety
and efficacy of the future treatments [17]. However, this
issue is complicated by the fact that a low level of pluri-
potency markers is also expressed in the primary human
limbal epithelium [18], and some of these markers are
critically involved in the regulation of stemness [19]. A
thorough understanding of the LSC differentiation hier-
archy and the functional roles of various LSC-related
markers is required to be able to address these questions.
Recently, Bojic et al. identified two novel corneal cell
surface proteins in primary cultured LSCs, namely,
CD200, which marks a small quiescent population, and
CD109, which is a marker for a more abundant prolifera-
tive progenitor cell type [20]. Both of these markers were
coexpressed with the ΔNp63 isoform and demonstrated
great proliferative capacity in vitro; however, only CD200-
positive cells generated holoclones that are a hallmark of a
self-renewing stem cell population in vitro. The more
detailed knowledge of the mutual relations among various
LSC markers and their exact positions in the functional
LSC hierarchy have remained largely unknown.
In recent years, it has become increasingly evident that
several stem cell niches in various tissues possess hetero-
genic stem cell subpopulations with distinct roles. For
example, in the well-studied gut epithelium, LGR5-posi-
tive intestinal stem cells (ISCs) are located at the bottom
of intestinal crypts together with nurturing Paneth cells,
from where their short-lived transiently amplifying cell
(TAC) progeny migrate towards the villi and terminally
differentiate into mature intestinal epithelial cell types. On
the other hand, it has been suggested that in the intestinal
niche, there is also quiescent subpopulations of LGR5-
negative ISCs, which upon injury activate to repopulate
both the intestinal epithelium and the LGR5-positive cell
pool, demonstrating the extreme flexibility of tissue repair
mechanisms in the intestine [21]. It is currently not
known whether corresponding stem cell compartments
can also be found in the limbus. Intriguingly however, it
has been shown that LSCs share some mutual markers
with ISCs, such as LGR5 [22, 23] and BMI1 [11], suggest-
ing potential stem cell compartmentalization in the limbal
niche as well.
In this study, we utilized our established protocol [24,
25] to address the question of whether distinct stem
cell populations can be identified during the in vitro
differentiation process of hPSC-derived LSCs. Extensive
characterization of the protein expression patterns
during the differentiation process was carried using a
set of putative stemness, LSC, and mature CE markers.
With this approach, we revealed the subsequent emer-
gence of three cell populations, each of which exhibited
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a different LSC-associated phenotype. The first two
populations appeared early during the process and con-
sisted mainly of cells with strong expression of ABCG2
but different levels of ΔNp63α. After this phase, the
population phenotype gradually shifted to form the
third population with strong expression of ΔNp63α and
no ABCG2. By employing the Wnt/BMP signaling
modifiers traditionally used for culturing ISCs, we were
able to regulate the maintenance of ABCG2-positive
hPSC-LSCs in vitro. Importantly, in the functional
experiments, these ABCG2-positive hPSC-LSCs dem-
onstrated increased regenerative potential in compari-
son to the cell population expressing the ΔNp63α-
positive phenotype.
Materials and methods
Experimental design
Initial experimental design and progression of the study
is presented in Fig. 1. The study consisted of two main
parts, the first being the detailed characterization of
hPSC differentiation process towards LSCs (Fig. 1a), and
the second being establishing novel culture conditions
for the maintenance of an ABCG2-positive LSC pheno-
type and further characterization of the stemness and
functionality of the distinct populations observed in in-
dicated time points and culture conditions (Fig. 1b). Full
descriptions of the cell culture and cell characterization
methods are provided as Supplemental Materials and
Methods (Additional file 1).
hPSC differentiation and hPSC-LSC culture
All three hPSC lines used in this study (hESC lines
Regea08/017 and Regea11/013 and hiPSC line
UTA.04607.WT) were derived and characterized in-
house, as described previously [26, 27]. Human PSC
cultures were routinely maintained in serum- and feeder
cell-free conditions and differentiated towards the
corneal epithelial lineage as described by Hongisto et al.
Fig. 1 Flow chart of the experimental design and progression. a Standard CnT-30-based hPSC-LSC differentiation protocol and characterization of
the hPSC-LSC differentiation process. b Novel CnT-07+ENRC-based hPSC-LSC maintenance protocol, characterization, and comparison of distinct
cell populations identified during the study. PSC pluripotent stem cell, UD-hPSC undifferentiated human PSC, LSC limbal stem cell, IF
immunofluorescence, qRT-PCR quantitative real-time PCR, LN-521 laminin-521, Col IV collagen type IV, E8 Flex, E8 Flex pluripotent stem cell
culture medium, CnT-30 CnT-30 corneal differentiation medium, CnT-07 CnT-07 epithelial proliferation medium, ENRC epidermal growth factor,
Noggin, R-Spondin-1, CHIR99021
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[24, 25]. In brief, UD-hPSCs were enzymatically dissoci-
ated to a single-cell suspension and transferred onto
low-attachment plates for induction. Formation of
embryoid bodies (EBs) was supported by adding 5 μM
blebbistatin (Sigma-Aldrich) to the defined XF-Ko-SR
medium for 1 day. During the following 3 days, XF-Ko-
SR was first supplemented with 10 μM SB-505124 and
50 ng/ml human basic fibroblast growth factor (bFGF;
PeproTech Inc., Rocky Hill, NJ) for 1 day and with 25
ng/ml bone morphogenetic protein (BMP)-4 (PeproTech
Inc.) for 2 days, to push the differentiation towards sur-
face ectoderm. EBs were then transferred onto plates
coated with 0.5 μg/cm2 recombinant laminin-521 (LN-
521, Biolamina, Sweden) and 5 μg/cm2 human placental
collagen Type IV (Col IV, Sigma-Aldrich) for adherent
differentiation in defined commercial CnT-30 corneal
differentiation medium (CELLnTEC Advanced Cell
Systems AG, Bern, Switzerland). Cells were thereafter
cultured in CnT-30, with medium changes three times
per week until subjected to characterization analyses or
further experimental settings. Throughout the article,
the term “CnT-30 differentiation/condition” refers to the
standard CnT-30-based differentiation protocol de-
scribed in this chapter. Representative cell morphology
during the differentiation was imaged with a Nikon
Eclipse TE2000-S microscope equipped with a DS-Fi1
camera (Nikon Instruments, Amsterdam, Netherlands).
Establishment of the ABCG2-positive hPSC-LSC culture
For maintenance of the ABCG2-positive population,
CnT-30 was replaced with CnT-07 (CELLnTEC Ad-
vanced Cell Systems AG, Bern, Switzerland) supple-
mented with ENRC (50 ng/ml mouse recombinant
epidermal growth factor (EGF, Invitrogen), 100 ng/ml
mouse recombinant Noggin, 1 μg/ml human recombin-
ant R-spondin (both from PeproTech), and 3 μM CHIR-
99021 (Stemgent)) at d10–11 of the standard CnT-30
differentiation protocol. New medium was introduced
directly to the adherent cultures; alternatively, the hPSC-
LSCs were concomitantly passaged onto fresh LN-521/
Col IV-coated wells at a density of 1 000 cells/cm2 in the
new medium. The cells were thereafter cultured follow-
ing the standard feeding regimen. After the emergence
of ABCG2-positive colonies in approximately 7–10 days,
further expansion of the ABCG2-positive hPSC-LSCs in
the ENRC medium was carried out by passaging subcon-
fluent cultures onto fresh LN-521/Col IV-coated ma-
trices at a density of 1 000 cells/cm2. Batches of the
passaged cells were also cryopreserved following our
routine cryopreservation protocol [24, 25]. Throughout
the article, the term “ENRC maintenance condition”
refers to the novel CnT-07-based, ENRC-supplemented
culture protocol described in this chapter.
Immunofluorescence
Immunofluorescence staining (IF) was utilized in several
stages during the study to analyze the protein expression
of the cells, as presented in Fig. 1. In the characterization
of standard hPSC-LSC differentiation in CnT-30, adherent
cultures of UD-hPSCs as well as hPSC-LSCs at d7, d9,
d11, d14, d17, d21, and d24 were stained with antibodies
against OCT3/4, PAX6, ABCG2, ΔNp63, p63α, CK14,
CK15, and CK12. Cytospin samples were prepared at d10
and d24 and stained with OCT3/4, ABCG2, p63α, ΔNp63,
CK14, and CK15 for quantification of the different popu-
lations by cell counting analysis. Two hPSC lines
(Regea08/017 and UTA.04607.WT) were used for the full
IF characterization, and the results were replicated with at
least two individual cell differentiation batches for both
lines. Expression of indicated markers during standard
differentiation of the third hPSC line, Regea11/013, was
analyzed less extensively at d10–11 and d24–25.
Adherent d10–11 and d21–24 hPSC-LSCs during Cnt-
30 differentiation as well as d21–24 hPSC-LSCs in
ENRC maintenance were stained against ABCG2, p63α,
LGR5, Ki67, and p27. Day 24 hPSC-LSCs in ENRC
maintenance were characterized also for their OCT3/4,
PAX6, CK14, and CK15 expression. Standard fixation
and IF procedures with primary and secondary anti-
bodies were performed essentially as described previ-
ously in Mikhailova et al. [28]. Raw images of the
stained cells were captured with an Olympus IX51 fluor-
escence microscope. ImageJ Image Processing and
Analysis tools [29] and Adobe Photoshop CC 2019 soft-
ware were used for cell counting and image processing,
respectively. Antibody specifics are provided as Supple-
mental Information (Additional file 2: Table S1).
Flow cytometry and fluorescence-activated cell sorting
UD-hPSCs and d10–11 and d24-d29 hPSC-LSCs during
Cnt-30 differentiation were characterized for their ABCG2
and CD200 surface antigen expression using flow cytome-
try. For practical reasons, cryopreserved d26–d29 hPSC-
LSCs were used in some repeats in place of freshly differ-
entiated cells, as we have previously demonstrated preser-
vation of the phenotype throughout this process [24].
Standard flow cytometry staining protocols were used in
the sample preparation, following the recommendations
provided by the antibody manufacturers. APC-conjugated
monoclonal mouse anti-human CD338 (ABCG2) antibody,
clone 5D3 (BD Pharmingen, #561451), and PE-conjugated
mouse monoclonal CD200 (clone OX-104) antibodies
from two manufacturers (BioLegend, #329205 and BD
Pharmingen, #561762) were used for indicated cell popula-
tions. An APC-conjugated mouse IgG2b κ antibody (BD
Pharmingen, #555745) or unstained cells were used as iso-
type and/or negative controls, respectively. CD200-stained
samples were also double-stained with ABCG2.
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For continued culture of pure ABCG2-positive cell
population, 1 000 Regea08/017 hPSC-LSCs staining
positive for ABCG2 at d11 were sorted directly onto
LN521/Col IV-coated wells in CnT-30 supplemented
with a 10 μM concentration of the Rho kinase inhibitor
Y-27632 (Tocris Bioscience) and were then cultured
following the standard feeding regimen for 17 days. The
sorted cells were stained in IF against p63α and ABCG2,
and expression of p63α was quantified by cell counting.
Both flow cytometry analyses and cell sorting were per-
formed using a BD FACSAria™ Fusion cell sorter operating
with the FACSDiva™ software (BD Biosciences, San Jose,
California, USA). At least 10 000 events were recorded
from the initially gated populations and analyzed with
FlowJo 10 software (BD Biosciences, San Jose, CA, USA).
Quantitative RT-PCR
UD-hPSCs and d10–11 and d21–24 hPSC-LSCs during
Cnt-30 differentiation as well as d21 hPSC-LSCs in the
ENRC maintenance were analyzed for their ABCG2
mRNA expression with qPCR, using a sequence-
specific TaqMan Gene Expression Assay for ABCG2
(#HS01053790_m1, Applied Biosystems). GAPDH
(Hs99999905_m1) was used as a housekeeping gene.
Standard methods were used for RNA isolation and
cDNA synthesis from the cell pellet samples collected
in indicated time points. All samples and controls were
run as triplicate reactions with the 7300 Real-Time
PCR system (Applied Biosystems). The results were
analyzed using the − 2ΔΔCt method [30] and are pre-
sented as the fold change in gene expression norma-
lized to GAPDH and relative to the UD controls.
Cell surface antigen screening
Cell surface marker screening was performed for the
Regea08/017 hPSC-LSCs at d10 during Cnt-30 differen-
tiation, using the LEGENDScreen™ Lyophilized Antibody
Array, Human PE Kit (BioLegend, #700007) and essen-
tially following the instructions of the manufacturer. The
experiment was carried out in four parts using 120 000–
150 000 cells per sample that were double-stained with
3 μl of APC-conjugated ABCG2 antibody (BD Pharmin-
gen, #561451). At least 10 000 initially gated events per
sample were recorded with FACSCanto II flow cyt-
ometer (BD Biosciences, San Jose, CA, USA) and
analyzed with FlowJo software. The results were com-
pared to the previously published screening data of
cultured primary human LSCs, produced by Bojic et al.
[20], with special emphasis on the two novel LSC
markers, CD109 and CD200.
Population doubling analyses
Population doubling calculations were carried out for
the Regea11/013 hPSC-LSCs cultured in ENRC, both
prior and after the standard cryopreservation protocols
described in Hongisto et al. [24]. Population doublings
(PDs) at the end of each subculture were calculated
using the following formula: log (N/N0)/log2, where N0
is the number of plated cells and N is the number of
cells at the end of the culture period. Similarly, the
population doubling time (PDT) for each passage was
calculated with the following formula: T × log2/log(N
−N0), where T is the duration of the culture in hours.
Ex vivo transplantation into a porcine cornea model
Porcine corneas were obtained and processed for cor-
neal ex vivo culture as previously described in [31, 32].
The excised corneas were maintained in CnT-CC
medium (CELLnTEC Advanced Cell Systems AG, Bern,
Switzerland) for up to 3 weeks prior to transplantation
experiments. LSCD mimicking state was induced to the
ex vivo corneas by placing a filter paper disc soaked
with 1 M sodium hydroxide (NaOH) onto the corneal
surface for 40 s, followed by thorough removal of the
epithelium by scraping.
Human PSC-LSCs cultured in CnT-30 and ENRC con-
ditions were seeded onto both sides of a fibrin carrier
membranes at a density of 30 000 cells/cm2 and thereafter
cultured for 2 additional weeks in their initial medium
conditions. The carrier membranes were transplanted into
the ex vivo corneas using four interrupted 9-0 Vicryl
sutures. Soft contact lenses were placed on top of the cor-
neas to prevent drying. After ex vivo transplantation, the
hPSC-LSCs from CnT-30 conditions were further
cultured in CnT-30 for 1 week (n = 2). The hPSC-LSCs
from ENRC conditions were cultured in CnT-07 for 1
week (n = 2) or CnT-30 for 2 weeks (n = 3). The medium
was gradually changed from CnT-07 + ENRC to CnT-30
through one intermediate step with 1:1 ratio of the two
media. During ex vivo culturing, all media were supple-
mented with 5% fetal bovine serum (FBS, Sigma-Aldrich),
1% penicillin/streptomycin and 0.1% amphotericin B
(Sigma-Aldrich). Media were replaced three times a week.
After 1 to 2 weeks, the ex vivo corneas were fixed, proc-
essed into paraffin-embedded tissue sections, and stained
with hematoxylin-eosin (HE), following the standard
methods. Images of the HE-stained tissue sections were
captured with the Nikon Eclipse TE2000-S microscope
and DS-Fi1 camera.
Statistical methods
All data are presented as the mean ± standard deviation
(SD). Whenever n ≥ 3, the Mann-Whitney U test was
performed to analyze the differences between the groups
using the GraphPad Prism 5 software (GraphPad Soft-
ware Inc.). Differences were considered statistically
significant when P ≤ 0.05.
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Results
Dissection of the hPSC-LSC differentiation hierarchy
reveals the subsequent emergence of three separate cell
populations, marked by distinct expression patterns for
ABCG2 and ΔNp63α
To investigate protein expression patterns during the
differentiation of hPSCs towards LSCs, UD-hPSCs
were differentiated towards the corneal lineage and
characterized using IF. During the time frame ranging
from d7 to d24, expression of OCT-3/4 was markedly
downregulated, whereas expression of PAX6, ΔNp63α,
CK15, and CK14 increased, indicating the emergence
of an LSC-like population (Fig. 2a). Interestingly,
ABCG2 was expressed only transiently, peaking be-
tween d9 and d11 and then gradually decreasing to
very low levels by d24 (Fig. 2a). In accordance with
our previous results [24], CK12 remained undetect-
able within this timeframe (data not shown). Quantifi-
cation of cell populations by protein expression
confirmed major differences between the d10 and d24
time points, as shown for the representative hESC
line (Regea08/017) in Fig. 2b. To be precise, the ex-
pression of ABCG2 decreased from 62.3% (SD 6.7) to
1.8% (SD 0.9), while the expression of ΔNp63α (as
demonstrated by double-staining with ΔNp63 and
p63α antibodies, Fig. 2c) increased from 23.2% (SD
14.1) to 54.3% (SD 6.2). CK15 and CK14 were un-
detectable at d10 but increased to 37.0% (SD 12.4)
and 56.2% (14.3) by d24, respectively. OCT3/4, on the
other hand, was expressed in less than 1.5% of the
cells at d10 and was further diminished to under 1%
by d24. Due to the distinct expression profiles of
ABCG2 and ΔNp63α during the differentiation
process, we further characterized the coexpression of
ABCG2 with p63α in d10 and d24. Interestingly, the most
intense expression of both markers was typically observed
in separate cell populations, as demonstrated in Fig. 2d
(see also Additional file 3: Figure S1), suggesting a transi-
tional rather than a stable phase for the coexpression. At
d10, ABCG2 and p63α were coexpressed in 31.6% of the
cells, whereas at d24 only 1% of the cells were double-
positive (Fig. 2e).
Flow cytometry confirmed the IF results by showing
that both UD-hPSCs and more differentiated d24–26
hPSC-LSCs had low expression of ABCG2 (0.8%, SD 1.3
and 1.5%, SD 2.0, respectively, for the representative
hESC line Regea08/017), whereas d10–11 hPSC-LSCs
expressed significantly higher levels of ABCG2 (21.6%,
SD 8.2) than both UD-hPSCs (P = 0.0238) and d24–26
hPSC-LSCs (P = 0.0275) (Fig. 2f, see also Additional file 4:
Figure S2A for representative flow cytometry plots).
Lower percentage of ABCG2 expressing cells in flow
cytometry in comparison to cytospin quantification is
likely in large part a technical issue related to the chosen
methods, as standard IF sample processing (including
permeabilization) also allows staining of the intracellular
ABCG2, resulting in more abundant positive signal,
whereas in live cell flow cytometry only the cells expres-
sing ABCG2 on their surface membrane label as positive.
Notably, isolation of ABCG2-positive hPSC-LSCs at
d11 leads to the formation of homogeneous hPSC-
LSC monolayers, with 99.9% (SD 0.2, n = 2800 cells)
nuclear p63α expression and very low to undetectable
levels of ABCG2 (Additional file 4: Figure S2B).
Additionally, changes in ABCG2 expression at the
mRNA level further verified notably higher expression
level of ABCG2 in the d10 hPSC-LSC population
than in UD-hPSCs and the d24 hPSC-LSC population
(Fig. 2g). Taken together, the characterization analyses
consistently demonstrated very distinct expression profiles
for the proposed LSC/progenitor markers ABCG2,
ΔNp63α, CK15, and CK14 between the d10–11 and d24
time points during the hPSC-LSC differentiation. Import-
antly, the described expression patterns were reproduced
with the hiPSC line UTA.04607.WT (Additional file 5:
Figure S3).
Screening of LSC-associated surface markers revealed a
high level of CD200-positive cells among d10 hPSC-LSCs
At d10 in Cnt-30 culture, Regea08/017 hPSC-LSCs
expressed several limbus-associated markers at levels
comparable to those of human primary cultured LSCs,
as reported by Bojic et al. [20] (Table 1). Furthermore,
we specifically investigated the two markers highlighted
by Bojic et al. as novel candidates for quiescent LSCs
and the proliferative progenitor phenotype, namely,
CD200 and CD109. CD200 was expressed at a con-
siderably higher level in our d10 hPSC-LSCs than in
cultured primary human LSCs (42.6% vs. 2.3%, respec-
tively). On the other hand, CD109 was expressed in
only 25.7% of hPSC-LSCs, in comparison to 56.3% of
primary cultured LSCs. Interestingly, ABCG2 was
expressed in approximately half of both the CD200-
and CD109-positive hPSC-LSC subpopulations, thus
showing no preferred coexpression with either of these
markers. To be precise, there were 48.1% ABCG2-posi-
tive and 51.9% ABCG2-negative cells in the CD200-
positive population, and in the CD109-positive popula-
tion, these numbers were 58.5% and 41.5%, respectively
(Additional file 6: Table S2).
As the role of CD200 was recently investigated also in
hPSC-derived corneal cells [33], we performed flow
cytometry analysis to further analyze the expression
pattern of CD200 during differentiation of hPSC-LSCs.
The results were consistent with both used CD200
antibodies, unambiguously showing that CD200 was
expressed in over 99% of UD-hPSCs (Fig. 3a). During
the Cnt-30 differentiation, CD200 expression decreased
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from 87.6% (SD 0.7) at d11 to 38.5% by d29 (Fig. 3b, c),
whereas ABCG2 expression followed a typical trend,
with low expression in 3.3% (SD 1.8) of UD-hPSCs, 57%
(SD 5.9) of d11 cells, and 7.4% (SD 0.9) of d29 cells
(Fig. 3a–c). Again, based on our results, the expression
pattern of CD200 did not correlate with that of
ABCG2, and in line with the screening results, there
were both ABCG2-positive and ABCG2-negative hPSC-
LSCs in the CD200-positive subpopulation. However,
we were unable to confirm this specific finding with IF
visualization using the unconjugated primary CD200-
antibody from BioLegend.
Fig. 2 Characterization of putative LSC marker expression during hPSC-LSC differentiation. a Representative morphology and protein expression
of the cultures at selected time points. Scale bars, 100 μm for all images in the same column. Cell nuclei counterstained with DAPI (blue). b
Marker expression differences in the d10 and d24 populations. Five images per sample and a minimum of 1400 cells per time point were
analyzed for each marker from cytospin samples. c Representative IF image of ΔNp63 and p63α double-staining in a d24 cytospin sample. Scale
bar, 100 μm for both c and d. d Representative IF image of ABCG2 and p63α double-staining in a d10 cytospin sample. e p63α and ABCG2
expression in d10 and d24 hPSC-LSCs. Five images per sample and a minimum of 3 000 cells per time point were analyzed from cytospin
samples. P > 0.05. f The level of ABCG2 protein expression in UD-hPSCs and in d10 and d24–26 hPSC-LSCs, analyzed with flow cytometry. g The
ABCG2 mRNA expression levels in UD-hPSCs and in d10 and d24 hPSC-LSCs analyzed with qRT-PCR. All representative data are presented with
the hESC line Regea08/017. All quantitative data are presented as the mean + SD, and n marks the individual cell differentiation batches serving
as biological replicates. Statistical analyses were carried out using the Mann-Whitney U test. *P ≤ 0.05
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Maintenance of ABCG2 expression during hPSC-LSC
culture is achieved with Wnt/BMP pathway signaling
modifiers previously established for the long-term
sustained growth of intestinal organoids in vitro
To study the properties of the ABCG2-positive cell
population in more detail, culture conditions aiming to
preserve the ABCG2 expressing cell population for
extended periods were established. Due to similarities
between the limbal and intestinal crypt stem cell niches
and the signaling pathways involved in the regulation of
stemness, we hypothesized that Wnt agonists and a
BMP antagonist previously used for intestinal crypt
organoid culture could be utilized for regulating the
differentiation process of hPSC-LSCs as well. Remark-
ably, replacing the corneal differentiation medium CnT-
30 with the epithelial maintenance medium CnT-07 and
specific combination of EGF, Noggin, R-spondin-1, and
CHIR-99201 (ENRC) at day 11 of differentiation,
resulted in the preservation of the colonial morphology
and strong ABCG2 protein expression that were observed
only transiently during the CnT-30 differentiation. The
main differences between the standard CnT-30-based dif-
ferentiation condition and the novel CnT-07+ENRC-based
maintenance condition are shown in Fig. 1. Notably,
colonies positive for ABCG2 in the ENRC condition
expressed only low levels of p63α, whereas time point-
matched cells in CnT-30 were ABCG2-negative and
p63α-“bright” (Fig. 4a). These IF results were con-
firmed with all three studied hPSC lines. Importantly,
the effect of the ENRC condition was consistent in all
lines, despite cell line-specific variations in the effi-
cacy. Prominent upregulation of ABCG2 at the
mRNA level in the ENRC condition in comparison to
the CnT-30 condition was confirmed also with qRT-
PCR using the hESC line Regea08/017 (Fig. 4b). Add-
itional characterization of PAX6, CK14, CK15, and
OCT3/4 expression in Regea11/013 hPSC-LSCs in the
maintenance condition demonstrated positive expres-
sion for PAX6, weak expression for CK14 and CK15,
and negative expression for OCT3/4 (Additional file 7:
Figure S4A).
ABCG2-positive limbal colonies coexpress the stem cell
marker LGR5
Due to the finding that ENRC supplementation, which
preserves LGR5-positive ISCs, also supports the main-
tenance of the ABCG2-positive LSC phenotype, we de-
cided to analyze the expression of LGR5 in our cells and
compare its expression pattern to those of both ABCG2
and ΔNp63. Indeed, prevalent expression of LGR5 was
observed during CnT-30 culture at d11, followed by
decreased expression upon further differentiation up to
Table 1 Expression of selected cell surface markers in d10
Regea08/017 hESC-LSCs
Surface marker hPSC-LSCs (%) Primary human LSCs [20] (%)
EGFR 97.7 88.8
CD71 81.9 88.8
Integrin β5 93.5 91.5
Integrin α6 (CD49f) 98.6 92.5
E-cadherin (CD324) 85.9 88.5
CD40 24.7 26.0
CD146 84.0 67.0
CD166 99.5 95.1
CD200 42.6 2.3
CD109 25.7 56.3
Fig. 3 CD200 and ABCG2 expression patterns during differentiation of hPSC towards LSCs, analyzed with flow cytometry. Scatter plots and
adjunct histograms as well as tables showing the distribution of cells in the CD200+/ABCG2− (Q1), CD200+/ABCG2+ (Q2), CD200−/ABCG2+ (Q3),
and CD200−/ABCG2− (Q4) subpopulations of UD-hPSCs (a) as well as at d11 (b) and d29 (c) during hPSC-LSC differentiation. For each sample,
10,000 initially gated events were analyzed, and the experiment was carried out once for the representative line Regea08/017
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d24. On the other hand, in time point-matched colonies
in ENRC, the expression of LGR5 was highly conserved
(Fig. 4c). Interestingly, at d11 during the CnT-30 culture,
LGR5 was coexpressed with ΔNp63, as marked by dis-
tinct membrane-localized staining at cellular junctions
of ΔNp63-positive cells (Fig. 4c). Further differentiation
under CnT-30 conditions, resulting in the formation of a
ΔNp63-positive epithelial monolayer, was accompanied
by concomitant loss of strong LGR5 expression on the
cell surface, a phenomenon similar to the expression
pattern of ABCG2. Under ENRC conditions, LGR5 ex-
pression was localized to cellular junctions, again similar
to ABCG2. Fascinatingly, as in the ENRC, the colonies
expressed only low levels of ΔNp63; LGR5 thus ap-
peared to switch its preferred coexpression with ABCG2
and ΔNp63, depending on the culture conditions.
ABCG2-positive hPSC-LSCs retain clonal growth and
proliferative capacity during passaging in the novel
maintenance condition
Population doubling analyses were carried out to deter-
mine the proliferative capacity of hPSC-LSCs. Under
ENRC maintenance, colony morphology and the
ABCG2/p63α expression pattern were preserved at least
up to passage 10 (Fig. 5a). As comparison, passaging and
subsequent culturing in CnT-30 medium resulted in loss
of the colony morphology and ABCG2 expression and
promoted further differentiation towards ΔNp63α-posi-
tive epithelial monolayers, as described for the hPSC-
LSC differentiation process (shown in, e.g., Fig. 4a). In
addition, the proliferation of hPSC-LSCs is rapidly
diminished upon passaging in CnT-30 and generally
ceases after the third passage, as repeatedly demon-
strated with various cell lines during our standard hPSC-
LSC cell culture routine.
To quantify the proliferative capacity of the cells,
Regea11/013 hPSC-derived LSCs were frequently pas-
saged under ENRC conditions, and their PDs and PDTs
were calculated. Freshly differentiated Regea11/013
hPSC-LSCs were cultured for five passages, during
which the cells went through over 20 population dou-
blings, with an average PDT of 50.9 h (SD 16.4) (Fig. 5b,
c, black line). Notably, cryopreservation between pas-
sages 2 and 3 (p2-p3) did not have a marked effect on
Fig. 4 Effect of culture conditions on hPSC-LSC morphology and p63α, ABCG2, and LGR5 expression. a Representative cell morphology and
p63α/ABCG2 protein expression under different culture conditions, as demonstrated by IF. Scale bars, 100 μm. b ABCG2 mRNA expression under
different conditions, analyzed with qRT-PCR in d21 cells. Data are presented as the mean + SD, n = 3 technical replicates from one sample, P >
0.05. c Characterization of LGR5 protein expression in relation to ABCG2 and ΔNp63 at d11, as well as after continued culture in CnT-07+ENRC or
CnT-30 at d24. Cell nuclei counterstained with DAPI (blue). Scale bars, 50 μm. Data shown for the representative hESC line Regea08/017
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Fig. 5 Marker expression and functional proliferative and regenerative properties of the ABCG2-positive hPSC-LSCs cultured in the novel
maintenance condition. a Morphology and p63α/ABCG2 expression pattern of hPSC-LSCs cultured in CnT-07+ENRC up to passages 0, 1, and 10.
Cell nuclei counterstained with DAPI (blue). Scale bars, black = 200 μm, white = 100 μm. b Population doublings and c population doubling times
of freshly differentiated hPSC-LSCs up to passage 5 and cryopreserved hPSC-LSCs up to passage 10. d Characterization of expression of the
quiescence marker p27 in relation to ABCG2 and ΔNp63 at d11, as well as after continued culture in CnT-07+ENRC or CnT-30 at d24. Scale bars,
100 μm. e Hematoxylin and eosin-stained sections of CnT-30-cultured Regea08/017 and CnT-07+ENRC-cultured Regea11/013 hPSC-LSCs after 1-
week and 2-week time points in the ex vivo porcine cornea model, respectively. Asterisk points out migrating cells. Scale bars, 500 μm and
100 μm, for all images in the panel. Data are presented for the hESC lines Regea11/013 (a–c, e) and Regea08/017 (d, e)
Vattulainen et al. Stem Cell Research & Therapy          (2019) 10:236 Page 10 of 15
the proliferative capacity of the cells after thawing
(Fig. 5b, c, blue line). After cryopreservation, the average
PDT of Regea11/013 hPSC-LSCs was 52.9 h (SD 13.5),
which was not significantly different than the PDT of
freshly differentiated cells prior to cryopreservation
(unpaired T test, P = 0.8086). In the course of eight
passages (from p3 to p10) under ENRC, cryopreserved
Regea11/013 hPSC-LSCs went through 36.6 population
doublings (Fig. 5b, blue line) without evident signs of
cellular senescence, as indicated by rather stable PDTs
(Fig. 5c, blue line).
ABCG2-positive hPSC-LSC colonies contain a
subpopulation of quiescent stem cells and demonstrate
regenerative potential in an ex vivo porcine cornea
model
We further investigated the proliferative status of the
distinct stem cell populations that emerged during CnT-
30 differentiation as well as under the ENRC condition,
by characterizing their expression of the proliferation
marker Ki67 and the quiescence-related marker p27.
Not surprisingly, Ki67 stained a large subpopulation of
cells during CnT-30 differentiation as well as in the
ABCG2-positive, clonally growing colonies in the ENRC
condition (Additional file 7: Figure S4). The ABCG2-
negative, presumably ΔNp63α-positive population at the
later time point also contained a large subpopulation of
Ki67-positive cells (Additional file 7: Figure S4B).
Interestingly, ABCG2-positive colonies under the
ENRC condition as well as at d11 during CnT-30 differ-
entiation contained subpopulations of quiescent cells
marked by strong nuclear localization of p27, whereas at
later time points in the CnT-30 culture, p27 expression
was markedly decreased. ΔNp63 and p27 expressions
were mutually exclusive in all the studied conditions
(Fig. 5d). Importantly, when transplanted into an ex vivo
porcine cornea model, the ENRC-cultured ABCG2-posi-
tive hPSC-LSCs produced a viable multilayered epithe-
lium with robust wound healing capacity, as indicated by
cells that had migrated to the sides of the carrier gel at
2-week time point (Fig. 5e, on the right). A monolayer of
ENRC-cultured cells was observed also at 1-week time
point (Fig. 5e, in the middle) whereas no CnT-30-cul-
tured ΔNp63α-positive hPSC-LSCs were observed to be
left in the ex vivo cornea cultures after this time (Fig. 5e,
on the left).
Discussion
Extensive research on the CE has established a solid base
for understanding the general aspects of its renewal.
However, further knowledge of the LSC population iden-
tity as well as the regulation of LSC maintenance and
activation in the human cornea is required to produce
more efficient and safer methods for clinical purposes.
One of the key challenges in developing hPSC-based treat-
ments has been the production and isolation of cell mater-
ial that robustly exhibits essential hallmarks of adult LSCs
and lacks the tumorigenic properties of PSCs. This task is
even more challenging because the identity of the LSCs is
still under debate. In this paper, we describe a detailed
phenotypic characterization of hPSC-derived LSCs during
differentiation and propose causal relationships between
acknowledged and novel LSC markers. Our results
suggest the existence of separate stem cell populations
within hPSC-LSCs that are similar to those that have been
previously identified, for example, in the bone marrow,
skin, and intestine [34]. Furthermore, in our study, the in
vitro maintenance of the cell population with LSC cha-
racteristics was achieved by modulating the Wnt and
BMP pathways, mimicking the maintenance conditions
commonly used for ISCs.
ΔNp63α is one of the most widely used LSC markers.
It has been reported that 10% of resting limbal basal
cells show nuclear ΔNp63α staining with stem cell pro-
perties. A fraction of these cells have been shown to
become activated upon injury and acquire a proliferative
ΔNp63α-positive phenotype [11]. Upon activation, LSCs
gradually lose their self-renewal properties along with
ΔNp63α expression and convert to TACs with limited
proliferation potential [8, 11]. In our culture environ-
ment, changes in the marker expression profile following
small-molecule induction and CnT-30-based standard
differentiation of hPSCs indicated a shift from pluripo-
tency towards the corneal epithelial lineage, as reported
previously by our group [24, 25, 28]. After being cultured
in CnT-30 conditions for 24 days, over 50% of the cells
expressed nuclear ΔNp63α, however, raising the question
of whether these cells still represented LSCs or had
already started to commit towards early TACs. Interes-
tingly, dissection of the developmental trajectory revealed
a transient expression phase (d9–11) of another potential
LSC marker, ABCG2. The membrane localization of
ABCG2, an efflux transporter, in these cells indicated that
this protein was able to attain a functional conformation
[35]. Surprisingly, the spatial expression of p63 and
ABCG2 both in vivo and in vitro has been poorly
addressed in the literature. In our study, coexpression of
ABCG2 and ΔNp63α upon early CnT-30 differentiation
was limited to under 32% of the cells and was reduced to
only 1% of the cells at d24, indicating a transitional rather
than coexpressional status of these markers. Furthermore,
the cells with robust ABCG2 expression and membrane
localization had relatively “dim” nuclear ΔNp63α staining,
whereas ΔNp63α-“bright” cells that appeared in the
culture upon further differentiation typically did not
express ABCG2. When selecting only the ABCG2-positive
cells for continued culture in the CnT-30 differentiation
medium, robust generation of a pure ABCG2-negative
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and p63α-“bright” epithelial monolayer was observed,
indicating that these cells originate from same founder
but undergo rapid early-stage lineage commitment in the
hPSC-LSC differentiation pathway.
To date, some discrepancy remains concerning
whether there is one slow-cycling LSC population that is
also able to self-renew [11] or two separate LSC popula-
tions, of which one is fully quiescent and the other
represents activated but slow-cycling LSCs that can
produce progeny for quiescence, self-renewal, and diffe-
rentiation [36]. To further elucidate the identity of the
hPSC-derived LSCs within the time-window showing
ABCG2 expression, we carried out an extensive screen-
ing analysis to compare our results to those previously
acquired with human primary LSCs by Bojic et al. [20].
Based on this comparison, many limbal proteins were
expressed similarly between hPSC-LSCs and primary
cells, apart from CD200 and CD109, novel cell surface
markers of putative quiescent and active LSCs, respec-
tively [20]. In our hPSC-LSC cultures at d10, the num-
ber of CD200-positive cells was much higher, which
could potentially be explained by the wide range of dif-
ferent cell types known to express this marker. In fact,
Hayashi et al. used CD200 as a negative selector for
hiPSC-derived corneal epithelial cells and reported a lack
of a CD200 signal in adult human and mouse corneas
[33]. However, in their study, the selection was per-
formed after 10–15 weeks of differentiation, at which
stage the remaining CD200-positive population may
already be committed to lineages other than the corneal
lineage. On the other hand, the lack of a signal from the
corneal tissue in the study by Hayashi et al. may be af-
fected by the time from death to retrieval of tissue,
which was not reported but should be kept short to
avoid the loss of stem cells. In our study, it is notable
that almost all of the ABCG2-positive cells were also
positive for CD200, indicating that a subpopulation of
CD200-expressing cells may also be LSC-like in the
hPSC-derived cultures. On the other hand, CD109 was
expressed in fewer hPSC-LSCs than primary LSCs [20],
possibly reflecting the rapid differentiation pace and
potential commitment of hPSC-LSCs towards the TAC
phenotype in CnT-30. Primary cell cultures also typically
contain nurturing limbal niche cells that support the
quiescence of LSCs [36, 37]. This environment is mim-
icked only partially in our cell cultures by chemical and
ECM signals, which could drive all or some of the
hPSC-LSCs into an activated state, as suggested by the
expression of the proliferation marker Ki67 by a large
number of the cells, including many of the ABCG2-posi-
tive cells. Regardless, it seems that a subpopulation of
the ABCG2-positive cells is actually quiescent in our
hPSC-LSC cultures based on immunostaining of p27, a
reversible cell cycle arrest marker [38]. Whether these
quiescent cells were also positive for CD200 warrants
further study with functional antibodies. In vivo, quies-
cence in the human limbus has been linked to ΔNp63α
positivity based on coexpression of ΔNp63α and p27
[11]. The p27 protein belongs to the Cip/Kip family of
cyclin-dependent kinase (CDK) inhibitor proteins that
prevent the activation of the cyclin E-CDK2 and cyclin
D-CDK4 complexes and control cell cycle progression at
G1, resulting in slower or arrested cell division. Import-
antly, to inhibit CDK, p27 needs to be localized in the
nucleus [39, 40]. In the study by Barbaro et al., IF from
human limbal tissue showed that p27 localized predom-
inantly in the cytoplasm and only weakly in the nucleus
[11], suggesting that the ΔNp63α/p27-expressing cells
may have been exiting the quiescent phase and/or repre-
sented slow-cycling cells. In our study, p27 staining in
cell cultures was predominantly nuclear, suggesting full
cell cycle arrest.
Wnt signals are an essential component of a wide
range of stem cell niches, including the limbus and the
intestine, and interestingly, renewal of the CE highly
resembles the regeneration of the gastrointestinal epithe-
lium. ISCs are located in the bottom of intestinal crypts,
from where their short-lived TA progeny migrate
towards the villi and terminally differentiate into mature
intestinal epithelial cell types. The differentiation mecha-
nisms of ISCs employing the Wnt/BMP regulatory
routes are currently well understood and have been suc-
cessfully applied to the ex vivo/in vitro study of ISCs
[41]. There are also studies suggesting similar regulation
of quiescence and stem cell activation/renewal by the
Wnt/BMP signaling pathways in the limbus. In general,
Wnt signaling and suppression of BMP are required for
LSC proliferation and maintenance of an uncommitted
state [42, 43]. However, the outcome appears to be
dependent on the culture system used, as the same
exogenous signals have been reported to have opposite
effects in explant versus isolated limbal cultures [44]. In
our study, we tested the effect of the ENRC growth
factor cocktail that activates Wnt signaling and inhibits
BMP and is commonly used for long-term ex vivo
culture of ISCs [41] on the differentiation and popula-
tion maintenance of hPSC-LSCs. Together with com-
mercial CnT-07 medium specifically designed for
epithelial proliferation instead of the corneal differenti-
ation medium CnT-30, ENRC supplementation led to
prolonged maintenance of ABCG2-positive cells. Similar
to the CnT-30 differentiation culture at d11, the ENRC-
cultured hPSC-LSCs expressed PAX6 and stained faintly
positive for the basal epithelial cytokeratins 14 and 15,
and the ABCG2-positive colonies were ΔNp63α-“dim”
and contained a subpopulation of p27-positive/ΔNp63α-
negative cells. However, unlike the CnT-30 cultured
ABCG2-negative/ΔNp63α-“bright” populations, ENRC
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maintained colonial growth of the cells until at least pas-
sage 10 without signs of cellular senescence, during
which time the cells underwent 37 population doublings.
Additionally, we found that LGR5, an established marker
for ISCs [45] and a suggested marker for LSCs [22, 23],
showed spatiotemporal coexpression with ABCG2 in
both CnT-30 cultures at d11 and ENRC cultures. It is
now commonly acknowledged that there are two pop-
ulations of ISCs with distinct roles. The LGR5-marked
stem cells reside in the crypt bottom adjacent to the
nurturing Paneth cells and are proliferative yet long-
lived, maintaining a rather undifferentiated phenotype.
These cells are the main population responsible for
producing the differentiating TAC progeny under
homeostatic conditions. On the other hand, the quies-
cent cells in the + 4 position do not contribute to
homeostatic regeneration but activate upon injury to
both repopulate the intestinal epithelium and depleted
LGR5-positive ISC pool. This process can also act vice
versa, and LGR5-positive cells can convert to + 4 cells,
demonstrating the extreme flexibility of tissue repair
mechanisms in the intestine. Due to the similarities in
marker expression and maintenance environment be-
tween ISCs and hPSC-LSCs identified in our study, it is
tempting to speculate the existence of similar popu-
lations in the limbus.
To summarize, during the differentiation of hPSC-
LSCs, we were able to identify three distinct populations
of (1) ABCG2-positive/ΔNp63α-negative quiescent cells,
(2) cells with stem cell characteristics expressing ABCG2
and LGR5 with “dim” ΔNp63α expression and a mode-
rate proliferation rate upon ENRC maintenance, and (3)
a later emerging population of highly proliferative
ΔNp63α/CK14/CK15-expressing cells, which could rep-
resent an early unspecified TAC phenotype (Fig. 6). A
deeper understanding of the functional roles of these
stem cell populations and their in-depth molecular
characterization may be utilized to unravel the functions
of different LSC phenotypes and the mechanisms of
corneal regeneration. Overall, these in vitro findings
suggest the heterogenic and/or plastic nature of limbal
progenitors and the potential concomitant operation of
both quiescent and actively proliferating stem cell com-
partments in the cornea. From a translational point of
view, it is important to consider the role of cellular
quiescence in therapeutic efficacy, as it has been specu-
lated whether stem cell therapies containing quiescent
cells might prove beneficial over approaches which
mainly include transplantation of proliferating LSCs and
their progeny [38, 46]. Thus, for ocular surface
applications such as treatment for LSCD, a graft that
also incorporates quiescent cells might better endure
Fig. 6 Proposed differentiation hierarchy of the LSC populations in the human cornea. a Schematic illustration of the human limbus, proposing
that populations of both quiescent (purple) and actively cycling (green) LSCs coexist in the limbal crypts, from where their TAC (blue) progeny
migrate towards the central cornea, going through several cell divisions before terminal differentiation into mature (white) CECs. b
Representation of the interplay between separate limbal cell populations, identified by distinct marker expression profiles. LSC limbal stem cell,
TAC transiently amplifying cell, CEC corneal epithelial cell
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transplantation-related cellular stress, leading to im-
proved long-term efficacy. This hypothesis was highly
supported by our data from the ex vivo transplantations
into the porcine cornea model that demonstrated super-
ior regenerative potential of the ABCG2-positive hPSC-
LSCs over the ΔNp63α-positive population. Importantly,
because ABCG2 identified both the quiescent and prolif-
erating hPSC-LSC populations, it could be envisioned as
a selection marker for new hPSC-based therapeutic
strategies to treat corneal blindness caused by LSCD.
Conclusions
In summary, this article describes an extensive
characterization of the corneal differentiation of human
pluripotent stem cells as well as a novel method to
maintain the stemness of the functional differentiated
limbal stem cells in culture. The study indicates new
relationships in the limbal stem cell hierarchy and iden-
tity, providing tools for further development of safe and
more efficient therapies for LSCD.
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